Results 301 to 310 of about 11,649,511 (362)

Drug-Drug Interactions of Antimalarial Drugs

2018
Malaria is the most important parasitic disease of humans accounting for high morbidity and mortality rates in the tropical and subtropical countries of Africa, Asia, and the Americas. Combination chemotherapy is recommended for treatment of acute uncomplicated malaria as a result of widespread drug resistance.
Tunde Balogun, Gene D. Morse, Fatai A. Fehintola, Waheed A. Adedeji   +3 more
openaire   +2 more sources

Iron as a Drug and Drug–Drug Interactions

2009
• Bioavailabiltiy of oral iron may be enhanced in the presence of reducing agents such as ascorbic acid.
Teresa V. Lewis, Tracy M. Hagemann
openaire   +2 more sources

Drug–drug interactions involving new antiretroviral drugs and drug classes

Current Opinion in Infectious Diseases, 2009
The aim of this article is to review the available data on new antiretroviral agents and the drug-drug interactions studied so far.Several new drugs have been recently approved or are under development for the treatment of HIV infection. The pharmacokinetics of these agents is being studied to provide information about safety and efficacy, and ...
Marta Sousa, Jesse Soodalter, Marta Boffito   +2 more
openaire   +3 more sources

Drug safety, drug quality, drug analysis

Journal of Pharmaceutical and Biomedical Analysis, 2008
Controlling and minimizing the side effects of drugs are the key issues in assuring the safety of drug therapy. Since side effects are inherent properties of the drug material, these cannot be influenced by drug analysts. At the same time drug analysts play a predominant role in assuring the quality of bulk drug materials and drug formulations and this
openaire   +2 more sources

Antibody–drug conjugates come of age in oncology

Nature reviews. Drug discovery, 2023
C. Dumontet, J. Reichert, P. Senter, J. Lambert, A. Beck   +4 more
semanticscholar   +1 more source

World Drug Report 2023

World Drug Report, 2023

semanticscholar   +1 more source

Drug repurposing: progress, challenges and recommendations

Nature reviews. Drug discovery, 2018
S. Pushpakom, Francesco Iorio, P. Eyers, K. J. Escott, Shirley Hopper, A. Wells, A. Doig, Tim Guilliams, Joanna Latimer, Christina McNamee, A. Norris, P. Sanseau, D. Cavalla, M. Pirmohamed   +13 more
semanticscholar   +1 more source

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Advanced Drug Delivery Reviews, 2001
Christopher, A. Lipinski, Beryl, W. Dominy, Paul, J. Feeney   +5 more
semanticscholar   +1 more source

A method for estimating the probability of adverse drug reactions

Clinical pharmacology and therapy, 1981
C. Naranjo, U. Busto, E. Sellers, P. Sandor, I. Ruiz, E. Roberts, E. Janecek, C. Domecq, D. Greenblatt   +8 more
semanticscholar   +1 more source

New colorimetric cytotoxicity assay for anticancer-drug screening.

Journal of the National Cancer Institute, 1990
P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. Mcmahon, D. Vistica, Jonathan T. Warren, H. Bokesch, S. Kenney, M. Boyd   +9 more
semanticscholar   +1 more source